38 related articles for article (PubMed ID: 14981951)
1. Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels.
Matsumoto K; Suzuki K; Koike H; Okamura K; Tsuchiya K; Uchida T; Takezawa Y; Kobayashi M; Yamanaka H
Anticancer Res; 2003; 23(6D):4953-8. PubMed ID: 14981951
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of vascular endothelial growth factor in patients with renal cell carcinoma: a systematic review of the literature and meta-analysis.
Shen H; Liu Q; Li M; Yang P
Clin Invest Med; 2017 Apr; 40(2):E40-E48. PubMed ID: 28447576
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Prognostic Effect of Plasma Fibrinogen in Renal Cell Carcinoma: A Meta-Analysis.
Tian Y; Hong M; Jing S; Liu X; Wang H; Wang X; Kaushik D; Rodriguez R; Wang Z
Biomed Res Int; 2017; 2017():9591506. PubMed ID: 28154828
[No Abstract] [Full Text] [Related]
4. Bioinformatics-driven identification of prognostic biomarkers in kidney renal clear cell carcinoma.
Verma VM; Puri S; Puri V
Front Nephrol; 2024; 4():1349859. PubMed ID: 38638111
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic mechanism of natural astaxanthin against renal clear cell carcinoma based on network pharmacology and bioinformatics].
Gao J; Yang D; Cao R; Pan X; Xia J
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1763-1772. PubMed ID: 35012906
[TBL] [Abstract][Full Text] [Related]
6. Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study.
Wei SC; Tsao PN; Wang YT; Lin BR; Wu DC; Tsai WS; Chen JS; Wong JM
Cancer Med; 2019 Jul; 8(7):3583-3591. PubMed ID: 31063258
[TBL] [Abstract][Full Text] [Related]
7. Upregulated
Wang X; Zhang J; Wang Y; Tu M; Wang Y; Shi G
Onco Targets Ther; 2018; 11():1697-1706. PubMed ID: 29618931
[TBL] [Abstract][Full Text] [Related]
8. The PLGF/c-MYC/miR-19a axis promotes metastasis and stemness in gallbladder cancer.
Li H; Jin Y; Hu Y; Jiang L; Liu F; Zhang Y; Hao Y; Chen S; Wu X; Liu Y
Cancer Sci; 2018 May; 109(5):1532-1544. PubMed ID: 29575299
[TBL] [Abstract][Full Text] [Related]
9. Accelerated growth of hemangioblastoma in pregnancy: the role of proangiogenic factors and upregulation of hypoxia-inducible factor (HIF) in a non-oxygen-dependent pathway.
Laviv Y; Wang JL; Anderson MP; Kasper EM
Neurosurg Rev; 2019 Jun; 42(2):209-226. PubMed ID: 29027018
[TBL] [Abstract][Full Text] [Related]
10. Performance of Circulating Placental Growth Factor as A Screening Marker for Diagnosis of Ovarian Endometriosis: A Pilot Study.
Zucchini C; De Sanctis P; Facchini C; Di Donato N; Montanari G; Bertoldo V; Farina A; Curti A; Seracchioli R
Int J Fertil Steril; 2016; 9(4):483-9. PubMed ID: 26985335
[TBL] [Abstract][Full Text] [Related]
11. A case study on the potential angiogenic effect of human chorionic gonadotropin hormone in rapid progression and spontaneous regression of metastatic renal cell carcinoma during pregnancy and after surgical abortion.
Mangel L; Bíró K; Battyáni I; Göcze P; Tornóczky T; Kálmán E
BMC Cancer; 2015 Dec; 15():1013. PubMed ID: 26704433
[TBL] [Abstract][Full Text] [Related]
12. The role of angiogenic factors in endometrial cancer.
Żyła MM; Kostrzewa M; Litwińska E; Szpakowski A; Wilczyński JR; Stetkiewicz T
Prz Menopauzalny; 2014 May; 13(2):122-6. PubMed ID: 26327841
[TBL] [Abstract][Full Text] [Related]
13. Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer.
Huang W; Zhu S; Liu Q; Li C; Li L
Int J Clin Exp Pathol; 2014; 7(12):8506-19. PubMed ID: 25674215
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum and tumor tissue endostatin evaluation in operable non-small cell lung cancer.
Hu MM; Hu Y; Zhang HQ; Jia WY; Qian Z; Yang Y; Li BL
Biomed Rep; 2014 Nov; 2(6):898-904. PubMed ID: 25279166
[TBL] [Abstract][Full Text] [Related]
15. The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer.
Lieu CH; Tran H; Jiang ZQ; Mao M; Overman MJ; Lin E; Eng C; Morris J; Ellis L; Heymach JV; Kopetz S
PLoS One; 2013; 8(10):e77117. PubMed ID: 24143206
[TBL] [Abstract][Full Text] [Related]
16. Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway.
Wei SC; Tsao PN; Weng MT; Cao Z; Wong JM
J Biomed Sci; 2013 Jun; 20(1):39. PubMed ID: 23799978
[TBL] [Abstract][Full Text] [Related]
17. Role of placenta growth factor in cancer and inflammation.
Kim KJ; Cho CS; Kim WU
Exp Mol Med; 2012 Jan; 44(1):10-9. PubMed ID: 22217448
[TBL] [Abstract][Full Text] [Related]
18. Minimally invasive colon resection is associated with a persistent increase in plasma PlGF levels following cancer resection.
Shantha Kumara HM; Cabot JC; Yan X; Herath SA; Luchtefeld M; Kalady MF; Feingold DL; Baxter R; Whelan RL
Surg Endosc; 2011 Jul; 25(7):2153-8. PubMed ID: 21184108
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma.
Heindryckx F; Mertens K; Charette N; Vandeghinste B; Casteleyn C; Van Steenkiste C; Slaets D; Libbrecht L; Staelens S; Starkel P; Geerts A; Colle I; Van Vlierberghe H
Mol Cancer; 2010 Aug; 9():219. PubMed ID: 20727157
[TBL] [Abstract][Full Text] [Related]
20. Perspectives in drug development for metastatic renal cell cancer.
Basu B; Eisen T
Target Oncol; 2010 Jun; 5(2):139-56. PubMed ID: 20689997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
